fda tirzepatide decision approves new weight-loss drug Zepbound (tirzepatide) FDA's tirzepatide decision creates uncertainty

Because of rising Type 2 diabetes and obesity rates around the globe, semaglutide use is skyrocketing

If you are in Chandler, AZ, and have been looking for an effective weight loss solution, its time to try GLP-1 medications

The injections are virtually painless and are typically given in the abdomen, thigh, or upper arm

A 2024 study compared the effects of oral semaglutide and injectable semaglutide on blood sugar levels and weight loss in people with type 2 diabetes

1,2 It is estimated that 20-50% 3 of individuals with diabetes are affected by gastroparesis, while 30% of individuals with gastroparesis have comorbid diabetes 4

Visual aids such as figures and trend graphs derived from clinical trial data further support the differences and similarities among these medications